These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 26096933

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes.
    Kuo MT, Savaraj N, Feun LG.
    Oncotarget; 2010 Aug; 1(4):246-51. PubMed ID: 21152246
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Collaboration Between RSK-EphA2 and Gas6-Axl RTK Signaling in Arginine Starvation Response That Confers Resistance to EGFR Inhibitors.
    Kuo MT, Long Y, Tsai WB, Li YY, Chen HHW, Feun LG, Savaraj N.
    Transl Oncol; 2020 Feb; 13(2):355-364. PubMed ID: 31887630
    [Abstract] [Full Text] [Related]

  • 7. Activation of Ras/PI3K/ERK pathway induces c-Myc stabilization to upregulate argininosuccinate synthetase, leading to arginine deiminase resistance in melanoma cells.
    Tsai WB, Aiba I, Long Y, Lin HK, Feun L, Savaraj N, Kuo MT.
    Cancer Res; 2012 May 15; 72(10):2622-33. PubMed ID: 22461507
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications.
    Zhu C, Wei Y, Wei X.
    Mol Cancer; 2019 Nov 04; 18(1):153. PubMed ID: 31684958
    [Abstract] [Full Text] [Related]

  • 10. Amino Acid Uptake Measured by [18F]AFETP Increases in Response to Arginine Starvation in ASS1-Deficient Sarcomas.
    Prudner BC, Sun F, Kremer JC, Xu J, Huang C, Sai KKS, Morgan Z, Leeds H, McConathy J, Van Tine BA.
    Theranostics; 2018 Nov 04; 8(8):2107-2116. PubMed ID: 29721066
    [Abstract] [Full Text] [Related]

  • 11. Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy.
    McAlpine JA, Lu HT, Wu KC, Knowles SK, Thomson JA.
    BMC Cancer; 2014 Aug 28; 14():621. PubMed ID: 25164070
    [Abstract] [Full Text] [Related]

  • 12. Hypoxia-induced nitric oxide production and tumour perfusion is inhibited by pegylated arginine deiminase (ADI-PEG20).
    Burrows N, Cane G, Robson M, Gaude E, Howat WJ, Szlosarek PW, Pedley RB, Frezza C, Ashcroft M, Maxwell PH.
    Sci Rep; 2016 Mar 14; 6():22950. PubMed ID: 26972697
    [Abstract] [Full Text] [Related]

  • 13. The GAS6-AXL signaling pathway triggers actin remodeling that drives membrane ruffling, macropinocytosis, and cancer-cell invasion.
    Zdżalik-Bielecka D, Poświata A, Kozik K, Jastrzębski K, Schink KO, Brewińska-Olchowik M, Piwocka K, Stenmark H, Miączyńska M.
    Proc Natl Acad Sci U S A; 2021 Jul 13; 118(28):. PubMed ID: 34244439
    [Abstract] [Full Text] [Related]

  • 14. Gas6-Axl signaling in presence of Sunitinib is enhanced, diversified and sustained in renal tumor cells, resulting in tumor-progressive advantages.
    Gustafsson A, Fritz HKM, Dahlbäck B.
    Exp Cell Res; 2017 Jun 01; 355(1):47-56. PubMed ID: 28327411
    [Abstract] [Full Text] [Related]

  • 15. Systems level profiling of arginine starvation reveals MYC and ERK adaptive metabolic reprogramming.
    Brashears CB, Barlin M, Ehrhardt WR, Rathore R, Schultze M, Tzeng SC, Van Tine BA, Held JM.
    Cell Death Dis; 2020 Aug 20; 11(8):662. PubMed ID: 32814773
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Discovery and Targeting of a Noncanonical Mechanism of Sarcoma Resistance to ADI-PEG20 Mediated by the Microenvironment.
    Rogers LC, Kremer JC, Brashears CB, Lin Z, Hu Z, Bastos ACS, Baker A, Fettig N, Zhou D, Shoghi KI, Dehner CA, Chrisinger JSA, Bomalaski JS, Garcia BA, Oyama T, White EP, Van Tine BA.
    Clin Cancer Res; 2023 Aug 15; 29(16):3189-3202. PubMed ID: 37339179
    [Abstract] [Full Text] [Related]

  • 20. Qigesan reduces the motility of esophageal cancer cells via inhibiting Gas6/Axl and NF-κB expression.
    Kong L, Wu Z, Zhao Y, Lu X, Shi H, Liu S, Li J.
    Biosci Rep; 2019 Jun 28; 39(6):. PubMed ID: 31110076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.